Stakeholders’ Consulting Group

Stakeholders’ Consulting Group 

ICE-HBV collaborates with key stakeholders to accelerate research in HBV cure. ICE-HBV Stakeholders’ Consulting Group gathers them annually to provide input on the development of ICE-HBV global research roadmap, share information about HBV cure programmes and identify potential synergies and collaborations areas.

The Stakeholders’ Consulting Group provides advice to researchers working towards the discovery of a safe, affordable, scalable and effective Hepatitis B cure.

The group is working on the following three pillars of HBV Cure preparedness, to ensure the timely and effective transition of research discoveries:

The Stakeholders Group has published this work.

In Stakeholders Group, in partnership with ICE-HBV, published the Hepatitis Commodities Access Systems & Cost Mapping resource. The mapping aims to increase awareness and information on cost and procurement within the hepatitis community, in order to increase access to viral hepatitis medicines and technologies in low-and-middle income countries, including HBV birth-dose vaccine, HBV treatment and HCV cure uptake

The Group has been co-chaired since late 2023 by Chari Cohen (Hepatitis B Foundation), Veronica Miller (HBV Forum), and Ulrike Protzer (DZIF). Tim Block (Hepatitis B Foundation) served as the past Chair.

Current Members:

Chairs:

NameEmail AddressOrganization NameCountry
Chari Cohenchari.cohen@hepb.orgHepatitis B FoundationUSA
Ulrike Protzerprotzer@tum.deDZIFGermany
Veronica Millerveronicam@berkeley.eduThe Forum for Collaborative ResearchUSA

Former Chair:

Timothy Blocktim.block@bblumberg.orgHepatitis B FoundationUSA

Full Group:

Alice Leealiceulee@gmail.comWorld Gastroenterology Organization Training Centres CommitteeAustralia
Alioune B. Coulibaly drcoul@gmail.comMali Health and Development Association APSAD/MALIMali
Amandine Verga-Gerard amandine.verga-gerard@anrs.fr
Amish LaxmidasAmish.Laxmidas@unitenetwork.orgUNITE – Parliamentarians Network to End HIV/AIDS, Viral Hepatitis and TuberculosisPortugal
Andrew Ballballa@who.intWHOSwitzerland
Anna KramvisAnna.Kramvis@wits.ac.zaICE-HBV +University of the WitwatersrandSouth Africa
Benjamin Cowiebenjamin.cowie@mh.org.auWHO Collaborating Centre for Viral Hepatitis at Royal Melbourne HospitalAustralia
Camila Picchiocamila.picchio@isglobal.orgBarcelona Institute for Global HealthSpain
Carla Coffincscoffin@ucalgary.caCanadian Hepatitis B NetworkCanada
Carol L. Brosgartcbrosgart@gmail.comIndependentUSA
Cary Jamescary.james@worldhepatitisalliance.orgThe World Hepatitis AllianceGlobal
Cecil Doviacecildovia@gmail.comCedaku Foundation/Ghana Health CentreGhana
Christian Bréchotchristian.brechot@pasteur.frICE-HBV+Global Virus NetworkUSA
Christian Ramerscramers.IC@clintonhealthaccess.orgClinton Health Access InitiativeUSA
Craig McClurecmcclure@clintonhealthaccess.orgClinton Health Access InitiativeCanada
David Huttondwhutton@umich.eduUniversity of MichiganUSA
Dee Leedee.lee@theinno.orgInno Community Development OrganisationChina
Elisabeth Pageelisabeth.page@cihr-irsc.gc.caCanadian Institutes for Health Research – IIICanada
Fatou Fallfatfall@hotmail.comHôpital Principal de DakarSenegal
Fernando Cairo fercairo@yahoo.comAsociación Argentina para el Estudio de las Enfermedades del HígadoArgentina
Fernando Contrerasfernandocontreras60@gmail.comALEHDominican Republic
François Dabisfrancois.dabis@u-bordeaux.frANRSFrance
Frank GJ Cobelensf.cobelens@aighd.orgAmsterdam Institute for Global Health and DevelopmentThe Netherlands
Funmi Lesilesio@who.intWHOSwitzerland
Gail MatthewsGmatthews@kirby.unsw.edu.auKirby InstituteAustralia
George Kalamitsisgkalamitsis@gmail.comPrometheusGreece
Giten Khwairakpamgiten.khwairakpam@treatasia.orgTreatAsiaThailand
Gregory Doregdore@kirby.unsw.edu.auKirby InstituteAustralia
Harry Janssenh.janssen@erasmusmc.nlInternational Symposium on Viral Hepatitis and Liver Disease (ISVHLD)Canada
Homie Razavidrazavishearer@cdafound.orgCDA FoundationUSA
Homie Razavihrazavi@cdafound.orgCDA FoundationUSA
Jack Wallacejack.wallace@burnet.edu.auBurnet InstituteAustralia
Jeffrey Lazarusjeffrey.lazarus@isglobal.orgBarcelona Institute for Global HealthSpain
Jennifer Johnstonjjohnston@cevhap.orgCEVHAPAustralia
Jessica HicksJessica.Hicks@worldhepatitisalliance.orgThe World Hepatitis Alliance
Jessica Weberjweber@forumresearch.orgThe Forum for Collaborative ResearchUSA
Jinlin Houjlhousmu@163.comNanfang Hospital, Southern Medical University, GuangzhouChina
Joerdis OttJoerdis.Ott@helmholtz-hzi.deHZIGermany
John Wardjward@taskforce.orgTask Force for Global Health/Coalition for Global Hepatitis EliminationUSA
Kevin Marriottkevin@hepatitisaustralia.comHepatitis AustraliaAustralia
Lindsey Hiebertlhiebert@taskforce.orgTask Force for Global Health/Coalition for Global Hepatitis EliminationUSA
Liudmyla Maistatlmaistat@medicinespatentpool.orgMPPSwitzerland
Manal El Sayedmanalhelsayed@yahoo.co.ukAin Shams UniversityEgypt
Margaret Hellardmargaret.hellard@burnet.edu.auBurnet InstituteAustralia
Margaret LittlejohnMargaret.Littlejohn@vidrl.org.auAustralian Centre for Hepatitis VirologyAustralia
Marie Capucine Penicaudmarie-capucine.penicaud@unimelb.edu.au / cpenicaud@endhep2030.orgICE-HBV+ EndHep2030Australia/France
Marinela Debumarinela.debu@elpa.euELPARomania
Marko Korenjak OR Marinela Debuelpa-president@elpa.euELPABelgium/Romania
Massimo Levreromassimo.levrero@gmail.comICE-HBV + ANRSFrance
Maud Lemoinem.lemoine@imperial.ac.ukMRC Unit – The GambiaGambia
Maureen Kamischkemaureen.kamischke@hepb.orgHepatitis B FoundationUSA
Mehlika Toymtoy@stanford.eduAsian Liver CenterUSA
Michael Ninburgmhninburg@gmail.comThe World Hepatitis AllianceUSA
Nick Walshnick.walsh@yahoo.comMonash UniversityAustralia
Niklas Luhmannluhmannn@who.intWHOSwitzerland
Noémi Tousignantn.tousignant@ucl.ac.ukUniversity College LondonUnited Kingdon
O. Fernandesofernandes@clintonhealthaccess.orgClinton Health Access Initiative
Patricia Vélez-Möllerpvelez2007@gmail.comAsociación Guatemalteca del Hígado y Asesor Regional de la Alianza Mundial de la Hepatitis para Las AméricasGuatemala
Peter Revillpeter.revill@mh.org.auICE-HBV + Doherty InstituteAustralia
Philippa Easterbrookeasterbrookp@who.intWHOSwitzerland
Philippa Matthewsphilippa.matthews@crick.ac.ukFrancis Crick Institute, UCL, LondonUK
Phoebe SchroderPhoebe.Schroder@ashm.org.auASHM
Ponsiano Ocamaponsiano.ocama@gmail.comMakerere University School of MedicineUganda
Rajen KoshiRKOSHY@niaid.nih.govNIAIDUSA
Raymundo Paranaunif@svn.com.brALEHBrazil
Roberts Lewisroberts.lewis@mayo.eduMayo ClinicGhana
Rosmawati Mohammedros@ummc.edu.myCEVHAPMalaysia
Sabrina Kalisabrina.kali@anrs.frANRSFrance
Ali Mondeladi.mondel@ashm.org.auHepatitis B Program Manager for the  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)Australia
Sam Sosamso@stanford.eduAsian Liver CenterUSA
Issy PurcellIsabelle.Purcell@ashm.org.auHepatitis B Program Manager for the  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)Australia
Sean Regan sregan@clintonHealthAccess.orgClinton Health Access InitiativeUSA
Silvana Lesidrenkasilvana@hepactive.orgHepactiveBulgaria
Su WangSu.wang@rwjbh.orgThe World Hepatitis AllianceUSA
Thomas Tut.tu@sydney.edu.auHep B ConnectAustralia
Timothy Halletttimothy.hallett@imperial.ac.ukImperial CollegeUnited Kingdom
Wangsheng Liwsli@endhep2030.orgEndHEP2030Hong Kong
Yazdan Yazdanpanahyazdan.yazdanpanah@inserm.fr
Brian McMahonbdm9@cdc.gov, bmcmahon@anthc.orgWorld Indigenous Peoples’ Conference on Viral HepatitisUSA
Kim Greenkgreen@path.org
Sonjelle ShiltonSonjelle.Shilton@finddx.orgDeputy Head HCV Access at the Foundation for Innovative New Diagnostics (FIND)Switzerland
Laura Broyleslbroyles@globalhealthig.comIndependent consultant in collaboration with the Global Health Impact GroupUSA
Ventzislava Petrov-Sanchezventzislava.petrov-sanchez@anrs.frANRSFrance
Hélène Kerthice.hbv@yahoo.comICE-HBV Management